Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
34,723,329
-
Total 13F shares
-
21,675,386
-
Share change
-
-1,332,603
-
Total reported value
-
$132,436,529
-
Put/Call ratio
-
60%
-
Price per share
-
$6.11
-
Number of holders
-
81
-
Value change
-
-$11,514,545
-
Number of buys
-
35
-
Number of sells
-
23
Institutional Holders of IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) as of Q4 2024
As of 31 Dec 2024,
IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,675,386 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, Siren, L.L.C., Redmile Group, LLC, Sanofi, BlackRock, Inc., GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, FMR LLC, and STATE STREET CORP.
This page lists
81
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.